Evidence map›Paper›PMID 34239724›Full record

ArticleJournal of ophthalmology2021

Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects.

Kitti Kormányos, Klaudia Kovács, Orsolya Németh, Gábor Tóth, Gábor László Sándor, Anita Csorba, Cecília Nóra Czakó, Achim Langenbucher, Zoltán Zsolt Nagy, Gergely Varga and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Kitti KormányosSemmelweis University, Department of Ophthalmology, Budapest, Hungary.ORCID https://orcid.org/0000-0003-1229-0570
Klaudia KovácsSemmelweis University, Department of Ophthalmology, Budapest, Hungary.
Orsolya NémethMarkusovszky University Teaching Hospital, Department of Ophthalmology, Szombathely, Hungary.ORCID https://orcid.org/0000-0002-5503-0595
Gábor TóthSemmelweis University, Department of Ophthalmology, Budapest, Hungary.ORCID https://orcid.org/0000-0002-9176-9442
Gábor László SándorSemmelweis University, Department of Ophthalmology, Budapest, Hungary.
Anita CsorbaSemmelweis University, Department of Ophthalmology, Budapest, Hungary.
Cecília Nóra CzakóSemmelweis University, Department of Ophthalmology, Budapest, Hungary.
Achim LangenbucherExperimental Ophthalmology, Saarland University, Homburg, Saarland, Germany.ORCID https://orcid.org/0000-0001-9175-6177
Zoltán Zsolt NagySemmelweis University, Department of Ophthalmology, Budapest, Hungary.ORCID https://orcid.org/0000-0002-7330-0464
Gergely Varga3 Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.ORCID https://orcid.org/0000-0001-6875-056X
László GopcsaSouth-Pest Central Hospital-National Institute for Hematology and Infectious Diseases, Department of Hematology and Stem Cell-Transplantation, Budapest, Hungary.
Gábor MikalaSouth-Pest Central Hospital-National Institute for Hematology and Infectious Diseases, Department of Hematology and Stem Cell-Transplantation, Budapest, Hungary.ORCID https://orcid.org/0000-0003-2204-7398
Nóra SzentmárySemmelweis University, Department of Ophthalmology, Budapest, Hungary.ORCID https://orcid.org/0000-0001-8019-1481
Semmelweis University · HUNational Center for Epidemiology · HUMarkusovszky Egyetemi Oktatókórház · HUSaarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo examine the ocular signs of monoclonal gammopathy and to evaluate ocular comorbidities in subjects with monoclonal gammopathy.

resultsThe OSDI score and best-corrected visual acuity (BCVA) were significantly worse in subjects with monoclonal gammopathy than in controls (

conclusionsOcular surface disease and cataract are more common, and BCVA is worse in patients with monoclonal gammopathy than in age-matched controls. Therefore, and due to the potential ocular signs and comorbidities of monoclonal gammopathy, we suggest a regular, yearly ophthalmic checkup of these patients to improve their quality of life.

Identifiers

PMID34239724
PMCPMC8235972
OpenAlexW3176493736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.